High-dose methotrexate-based regimens with or without vincristine for the treatment of primary central nervous system lymphoma.
High-dose methotrexate-based regimens with or without vincristine for the treatment of primary central nervous system lymphoma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa077.